Literature DB >> 21932123

Dyspnea as a prognostic factor in anaplastic thyroid carcinoma.

Lauren Tashima1, Ron Mitzner, Saima Durvesh, David Goldenberg.   

Abstract

Anaplastic thyroid cancer (ATC) is a rare but aggressive form of thyroid cancer. In this study, we review a single institution's experience with ATC over past 34 years. Through retrospective review, we attempted to identify the prognostic factors affecting the survival at our institution. We reviewed the records of 33 patients diagnosed with ATC by pathology over the last three decades. At our institution, median age at diagnosis was 68 years, the male to female ratio was 1.1:1, mean survival was 10 months and median survival was 4.7 months. Thirty-nine percentage of patients were treated with chemotherapy and 52% received radiation treatment. Thirty-six percentage received both chemotherapy and radiation and 58% of patients were treated with surgical intervention. Four of the patients received surgical intervention with curative intent. Tracheotomy was performed in 40% of patients. Eight patients survived more than 10 months. Univariate analysis showed that age greater than 60 and dyspnea at presentation were associated with decreased survival and that surgical intervention was associated with increased survival. Multivariate analysis identified only dyspnea at the time of presentation to be a significant independent prognostic factor affecting the mortality. While long-term survival is possible in some patients, ATC has a poor prognosis despite the attempts at aggressive treatment. In this study, we report that dyspnea was the only independent factor found to negatively affect the survival. This finding is unique in our study and supports the role of using signs at the time of presentation as potential prognostic factors for those patients with this aggressive disease.

Entities:  

Mesh:

Year:  2011        PMID: 21932123     DOI: 10.1007/s00405-011-1762-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  14 in total

1.  Prognostic factors for Korean patients with anaplastic thyroid carcinoma.

Authors:  Tae Yong Kim; Kyung Won Kim; Tae Sik Jung; Jung Min Kim; Sun Wook Kim; Ki-Wook Chung; Eun Young Kim; Gyungyub Gong; Young Lyun Oh; Soo Youn Cho; Ka Hee Yi; Won Bae Kim; Do Joon Park; Jae Hoon Chung; Bo Youn Cho; Young Kee Shong
Journal:  Head Neck       Date:  2007-08       Impact factor: 3.147

2.  Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.

Authors:  P I Haigh; P H Ituarte; H S Wu; P A Treseler; M D Posner; J M Quivey; Q Y Duh; O H Clark
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

3.  Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.

Authors:  Electron Kebebew; Francis S Greenspan; Orlo H Clark; Kenneth A Woeber; Alex McMillan
Journal:  Cancer       Date:  2005-04-01       Impact factor: 6.860

Review 4.  Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.

Authors:  R C Smallridge; J A Copland
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-04-24       Impact factor: 4.126

5.  [Problems of tracheotomy in locally invasive anaplastic thyroid cancer].

Authors:  T Hölting; H Meybier; H Buhr
Journal:  Langenbecks Arch Chir       Date:  1989

Review 6.  Anaplastic (undifferentiated) thyroid cancer: improved insight and therapeutic strategy into a highly aggressive disease.

Authors:  J P O'Neill; B O'Neill; C Condron; M Walsh; D Bouchier-Hayes
Journal:  J Laryngol Otol       Date:  2005-08       Impact factor: 1.469

Review 7.  Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.

Authors:  Robert C Smallridge; Laura A Marlow; John A Copland
Journal:  Endocr Relat Cancer       Date:  2008-11-05       Impact factor: 5.678

Review 8.  Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach.

Authors:  Michael J Veness; Guy S Porter; Gary J Morgan
Journal:  ANZ J Surg       Date:  2004-07       Impact factor: 1.872

9.  Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002.

Authors:  Jergin Chen; Jonathan D Tward; Dennis C Shrieve; Ying J Hitchcock
Journal:  Am J Clin Oncol       Date:  2008-10       Impact factor: 2.339

Review 10.  Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches.

Authors:  Chandrakanth Are; Ashok R Shaha
Journal:  Ann Surg Oncol       Date:  2006-02-15       Impact factor: 5.344

View more
  6 in total

1.  Influence of risk grouping on therapeutic decisions in patients with anaplastic thyroid carcinoma.

Authors:  Chuanzheng Sun; Chao Li; Zedong Hu; Xiaojiang Li; Jiehua He; Ming Song; Guojun Li; Fenghua Zhang; Qiuli Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-10       Impact factor: 2.503

2.  Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation.

Authors:  Zhaoming Zhong; Zedong Hu; Yue Jiang; Ruimei Sun; Xue Chen; Hongying Chu; Musheng Zeng; Chuanzheng Sun
Journal:  Oncotarget       Date:  2016-09-13

3.  2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.

Authors:  Keith C Bible; Electron Kebebew; James Brierley; Juan P Brito; Maria E Cabanillas; Thomas J Clark; Antonio Di Cristofano; Robert Foote; Thomas Giordano; Jan Kasperbauer; Kate Newbold; Yuri E Nikiforov; Gregory Randolph; M Sara Rosenthal; Anna M Sawka; Manisha Shah; Ashok Shaha; Robert Smallridge; Carol K Wong-Clark
Journal:  Thyroid       Date:  2021-03       Impact factor: 6.568

4.  Two cases of cervical hemorrhage with upper airway obstruction: a life-threatening condition.

Authors:  Enrico Maria Amadei; Laura Benedettini; Ottavio Piccin
Journal:  Case Rep Med       Date:  2014-01-30

5.  Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma.

Authors:  Xiayun He; Duanshu Li; Chaosu Hu; Zhuoying Wang; Hongmei Ying; Yi Wu
Journal:  BMC Cancer       Date:  2014-04-02       Impact factor: 4.430

6.  Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in China.

Authors:  Chuanzheng Sun; Qiuli Li; Zedong Hu; Jiehua He; Chao Li; Guojun Li; Xiaofeng Tao; Ankui Yang
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.